021-51111890
购物车（0）
sales@molnova.cn
IGF-I 24-41
CAS No. 135861-49-3
IGF-I 24-41 ( Insulin-like Growth Factor I (24-41) )
产品货号. M29823 CAS No. 135861-49-3
IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称IGF-I 24-41
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
-
产品描述IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
-
体外实验——
-
体内实验IGF-I (24-41) (ICV; 200 ng dose; 2 μL; postnatal days 2, 4, and 7) regulates somatic growth and behavioral development. Animal Model:Mice of an outbred Swiss-derived strain (CD-l) weighing 30-33g (virgin males) or 28-30g (nulliparous females)Dosage:200 ng dose; 2 μL Administration:ICV; postnatal days (PND) 2, 4, and 7 Result:Increased the rate of ultrasonic calls of the pups measured on PND8.
-
同义词Insulin-like Growth Factor I (24-41)
-
通路Angiogenesis
-
靶点IGF-1R
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number135861-49-3
-
分子量2017.16
-
分子式C88H133N27O28
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : 50 mg/mL (24.79 mM助)
-
SMILES——
-
化学全称Sequence:{Tyr}{Phe}{Asn}{Lys}{Pro}{Thr}{Gly}{Tyr}{Gly}{Ser}{Ser}{Ser}{Arg}{Arg}{Ala}{Pro}{Gln}{Thr}
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Puche JE, et al. Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med. 2012 Nov 14;10:224.
产品手册
关联产品
-
BMS-754807
BMS-754807 (BMS 754807, BMS754807) 是一种有效、可逆、口服活性的 IGF-1R/胰岛素受体抑制剂，IC50 分别为 1.8 和 1.7 nM。
-
NT157
NT157是一种靶向IRS蛋白的小分子酪氨酸磷酸化抑制剂，有可能抑制TME癌细胞和基质细胞中的IGF-1R和STAT3信号通路，导致癌细胞存活率降低。
-
NVP-ADW742
NVP-ADW742 是一种 IGF-1R 抑制剂，IC50 为 0.17 μM。
